SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-300417
Filing Date
2023-12-21
Accepted
2023-12-21 08:05:52
Documents
12
Period of Report
2023-12-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d575238d8k.htm   iXBRL 8-K 30716
  Complete submission text file 0001193125-23-300417.txt   156734

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eq-20231221.xsd EX-101.SCH 2849
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20231221_lab.xml EX-101.LAB 18739
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20231221_pre.xml EX-101.PRE 11709
6 EXTRACTED XBRL INSTANCE DOCUMENT d575238d8k_htm.xml XML 3512
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 231502850
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)